Pure Small Cell Carcinoma of the Prostate: A Case Report and Literature Review

被引:15
作者
Capizzello, Antonio [1 ]
Peponi, Evangelia [1 ]
Simou, Nafsika [2 ]
Ntaskagiannis, Dimitrios [1 ]
Tasiou, Ifigenia [1 ]
Kamina, Sevasti [2 ]
Tsekeris, Periklis [1 ]
机构
[1] Univ Hosp Ioannina, Radiat Therapy Dept, GR-45500 Ioannina, Greece
[2] Univ Hosp Ioannina, Pathol Dept, Ioannina, Greece
来源
CASE REPORTS IN ONCOLOGY | 2011年 / 4卷 / 01期
关键词
Prostate cancer; Small cell carcinoma; Neuroendocrine differentiation;
D O I
10.1159/000324717
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
/Primary small cell carcinoma of the prostate (SCPCa) is a rare pathologic entity with unique clinical features and a poor prognosis. We present a case of a patient diagnosed with pure SCPCa treated with a combined chemo-radiotherapeutic approach. Pathological findings showed that the neoplastic cells exhibited positivity for pancytokeratin, synaptophysin, thyroid transcription factor-1 and CD56. Immunostaining for prostate-specific antigen was negative, while serum prostate-specific antigen was within normal limits. We review the available literature to gain additional information about diagnosis, treatment and prognosis of pure SCPCa.
引用
收藏
页码:88 / 95
页数:8
相关论文
共 18 条
  • [1] Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO
  • [2] 2-S
  • [3] CHEMOTHERAPY FOR SMALL-CELL CARCINOMA OF PROSTATIC ORIGIN
    AMATO, RJ
    LOGOTHETIS, CJ
    HALLINAN, R
    RO, JY
    SELLA, A
    DEXEUS, FH
    [J]. JOURNAL OF UROLOGY, 1992, 147 (03) : 935 - 937
  • [4] Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center
    Asmis, TR
    Reaume, MN
    Dahrouge, S
    Malone, S
    [J]. BJU INTERNATIONAL, 2006, 97 (04) : 711 - 715
  • [5] DISANTAGNESE PA, 1992, CANCER-AM CANCER SOC, V70, P254, DOI 10.1002/1097-0142(19920701)70:1+<254::AID-CNCR2820701312>3.0.CO
  • [6] 2-E
  • [7] Undifferentiated carcinoma of the prostate with small cell features:: immunohistochemical subtyping and reflections on histogenesis
    Helpap, B
    Köllermann, J
    [J]. VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 434 (05): : 385 - 391
  • [8] Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases
    Koutsilieris, M
    Mitsiades, CS
    Bogdanos, J
    Dimopoulos, T
    Karamanolakis, D
    Milathianakis, C
    Tsintavis, A
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4398 - 4405
  • [9] Vascular Endothelial Growth Factor-C Protects Prostate Cancer Cells from Oxidative Stress by the Activation of Mammalian Target of Rapamycin Complex-2 and AKT-1
    Muders, Michael H.
    Zhang, Heyu
    Wang, Enfeng
    Tindall, Donald J.
    Datta, Kaustubh
    [J]. CANCER RESEARCH, 2009, 69 (15) : 6042 - 6048
  • [10] SMALL-CELL ANAPLASTIC CARCINOMA OF THE PROSTATE - A CLINICAL, PATHOLOGICAL AND IMMUNOHISTOLOGICAL STUDY OF 27 PATIENTS
    OESTERLING, JE
    HAUZEUR, CG
    FARROW, GM
    [J]. JOURNAL OF UROLOGY, 1992, 147 (03) : 804 - 807